The aircraft is not yet on the ground, but the approach has been uneventful so far. As tired as the metaphor may be, a “soft landing” is the best possible outcome of the Federal Reserve’s belated efforts to defeat inflation. And the latest data suggests it could be happening. The Fed will announce its next …
Dec 7 (Reuters) – China on Wednesday announced the most sweeping changes to its strict zero COVID policy since the pandemic began three years ago, easing rules that had curbed the spread of the virus but had hobbled the world’s second-largest economy worldwide and sparked protests. The easing of rules, which include allowing infected people …
Reaction to China’s easing of COVID restrictions in major policy shift Read More »
Foxconn says it is working with staff to resolve disputes Major iPhone factory rocked by protests over wages and conditions Apple says it has a team on the ground in Zhengzhou TAIPEI/SHANGHAI, Nov 24 (Reuters) – Foxconn (2317.TW) said on Thursday that a payroll-related “technical error” occurred when hiring new hires at a coronavirus-hit iPhone …
Foxconn apologizes for payroll error at Chinese iPhone factory after workplace unrest Read More »
Some local business news since our last update in August. Construction of the Bay Street “Dinning Terrace” continues with construction of Uchiwa Ramen, Shake Shack and Arthur Mac’s Little Snack progressing steadily. The previously advertised Sababa Israeli street food is no longer listed on the Bay Street website. Previously announced Core Power Yoga open at …
Text size A rise in unemployment to below 5% would be the mildest recession in post-war US history, writes Joseph E. Gagnon. Graeme Sloan/Bloomberg About the Author: Joseph E. Gagnon is a senior fellow at the Peterson Institute for International Economics and a former head of the Federal Reserve. The coming recession could be the …
Trials show small benefit, but without statistical validity Roche setback leaves Biogen and Eisai as leaders in the field It’s up to Roche’s CEO-designate to revive development fortunes Roche shares down 3.4%, its development partner Morphosys down 29% Nov 14 (Reuters) – Roche’s (ROG.S) Alzheimer’s drug candidate has not been shown to slow the progression …
Roche’s Alzheimer’s drug fails in long-awaited trial Read More »
